Harbin Gloria Pharmaceuticals Co.,Ltd. Posted 289.5 Million Yuan Net Loss in 2022

Harbin Gloria Pharmaceuticals Co.,Ltd. (哈尔滨誉衡药业股份有限公司) (002437.SZ) reported a net loss of 289.5 million yuan in 2022, reversing a net profit of 53.8 million yuan for the previous year.

Meanwhile, the company posted 3.1 billion yuan in revenue, down 1.2% year-on-year.

At the end of the reporting period, it had 4.1 billion yuan in total assets and 2.4 billion yuan in total liabilities, with a liability-to-asset ratio of 58.2%.